Experimental burn wound sepsis: variations in response to topical agents.
D000818:Animals; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D002056:Burns / Q000150:complications*; D007773:Lactates / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa; D051381:Rats; D011919:Rats, Inbred Strains; D012836:Silver Proteins / Q000627:therapeutic use; D013411:Sulfadiazine / Q000008:administration & dosage / Q000627:therapeutic use; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use; D014946:Wound Infection / Q000188:drug therapy*
D000891:Anti-Infective Agents, Local; D007773:Lactates; D012836:Silver Proteins; D013449:Sulfonamides; D013411:Sulfadiazine